Clearing the air: a review of our current understanding of "chemo fog". (Q38088668)

28 August 2017

Clearing the air: a review of our current understanding of "chemo fog". (English)

1 reference

28 August 2017

Erin O'Farrell

1

1 reference

28 August 2017

Joyce MacKenzie

series ordinal

2

1 reference

28 August 2017

Barbara Collins

series ordinal

3

1 reference

28 August 2017

1 June 2013

1 reference

28 August 2017

Current Oncology Reports

1 reference

28 August 2017

15

1 reference

28 August 2017

3

1 reference

28 August 2017

260-269

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-013-0307-7

28 August 2017

0 references

cites work

Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The menopause and HRT. HRT and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Estrogen and cognitive functioning in women: lessons we have learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive impairment associated with adjuvant therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Estrogen- and tamoxifen-associated effects on brain structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The effects of hormone therapy on cognition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Prechemotherapy alterations in brain function in women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

'Chemobrain' in breast carcinoma?: a prologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Subjective cognitive dysfunction in breast cancer patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Structural Brain Differences in Breast Cancer Patients Compared to Matched Controls Prior to Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

21 January 2018

Renaming "chemobrain"

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

"Doctor, will the treatment you are recommending cause chemobrain?".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Effects of adjuvant treatment on cognitive function in women with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The effects of chemotherapy on cognitive function in a mouse model: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Prefrontal cortex and executive function impairments in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive speed of processing and functional declines in older cancer survivors: an analysis of data from the ACTIVE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Predictors of cognitive decline after chemotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cancer as a risk factor for long-term cognitive deficits and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-013-0307-7

MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma.

21 January 2018

1 reference

12 December 2020

White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support

1 reference

12 December 2020

The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy

1 reference

12 December 2020

ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy

1 reference

12 December 2020

Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging

1 reference

12 December 2020

Long-term cancer survivors experience work changes after diagnosis: results of a population-based study

1 reference

12 December 2020

White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.

1 reference

12 December 2020

Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.

1 reference

12 December 2020

10.1007/S11912-013-0307-7

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference